Home Cart 0 Sign in  

[ CAS No. 144120-53-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 144120-53-6
Chemical Structure| 144120-53-6
Structure of 144120-53-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 144120-53-6 ]

Related Doc. of [ 144120-53-6 ]

Alternatived Products of [ 144120-53-6 ]

Product Details of [ 144120-53-6 ]

CAS No. :144120-53-6 MDL No. :MFCD00467715
Formula : C22H21NO6 Boiling Point : -
Linear Structure Formula :- InChI Key :ZJMVIWUCCRKNHY-IBGZPJMESA-N
M.W : 395.41 Pubchem ID :7020604
Synonyms :
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(allyloxy)-4-oxobutanoic acid
Chemical Name :Fmoc-Asp-OAll

Calculated chemistry of [ 144120-53-6 ]

Physicochemical Properties

Num. heavy atoms : 29
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.23
Num. rotatable bonds : 11
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 105.21
TPSA : 101.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.47 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.37
Log Po/w (XLOGP3) : 3.16
Log Po/w (WLOGP) : 3.1
Log Po/w (MLOGP) : 2.27
Log Po/w (SILICOS-IT) : 3.23
Consensus Log Po/w : 2.83

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.86
Solubility : 0.0543 mg/ml ; 0.000137 mol/l
Class : Soluble
Log S (Ali) : -4.97
Solubility : 0.00423 mg/ml ; 0.0000107 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.39
Solubility : 0.00159 mg/ml ; 0.00000403 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.16

Safety of [ 144120-53-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 144120-53-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 144120-53-6 ]
  • Downstream synthetic route of [ 144120-53-6 ]

[ 144120-53-6 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 144120-52-5 ]
  • [ 144120-53-6 ]
YieldReaction ConditionsOperation in experiment
87% With trifluoroacetic acid In dichloromethane at 20℃; for 1 h; Synthesis of Nα-Fmoc-L-aspartic acid (OH) allylester [8] [0150] DCM (4 ml) and TFA (2 ml) was added and stirred for 1 h at RT. After evaporation to dryness the solid was dissolved in sat. NaHCO3, washed with ether, acidified (pH 2) with HCl (5percent) to form a white precipitate that was extracted two times with EE. The organic layer was washed with acidified water (HCl, pH 1), dried (Na2SO4) and evaporated under reduced pressure to yield [8] (0.77 g; 1.94 mmol; 87percent yield) [0152] 1H NMR (250 MHz, DMSO): δ 7.90 (m, 2H,), 7.83 (m, 1H), 7.70 (d, 2H), 7.42 (m, 2H), 7.32 (m, 2H), 5.87 (m, 1H), 5.30 (d, 1H), 5.18 (m, 1H), 4.58 (d, 2H), 4.45 (m, 1H), 4.26 (m, 3H), 2.70 (m, 2H), 13C NMR (75 MHz, CDCl3): 171.85, 171.29, 144.22, 141.20, 132.72, 128.11, 127.540, 125.66 120.59, 118.03, 66.24, 65.52, 51.02, 47.07, 36.32. Rt (10-100percent): 22.0 min. ESI (m+Na): 418.1.
Reference: [1] Tetrahedron Letters, 1992, vol. 33, # 32, p. 4557 - 4560
[2] Chemical Communications, 2011, vol. 47, # 39, p. 10939 - 10941
[3] Carbohydrate Research, 2007, vol. 342, # 3-4, p. 541 - 557
[4] Journal of Medicinal Chemistry, 2011, vol. 54, # 21, p. 7648 - 7662
[5] Patent: US2014/39153, 2014, A1, . Location in patent: Paragraph 0150; 0151; 0152
[6] Journal of the American Chemical Society, 2003, vol. 125, # 40, p. 12100 - 12101
[7] Journal of Organic Chemistry, 2004, vol. 69, # 18, p. 6131 - 6133
[8] Tetrahedron Letters, 1993, vol. 34, # 10, p. 1549 - 1552
[9] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 12, p. 1667 - 1672
  • 2
  • [ 136083-57-3 ]
  • [ 107-18-6 ]
  • [ 144120-53-6 ]
Reference: [1] Synthesis, 2009, # 5, p. 809 - 814
  • 3
  • [ 71989-14-5 ]
  • [ 144120-53-6 ]
Reference: [1] Tetrahedron Letters, 1993, vol. 34, # 10, p. 1549 - 1552
[2] Tetrahedron Letters, 1993, vol. 34, # 10, p. 1549 - 1552
[3] Tetrahedron Letters, 1992, vol. 33, # 32, p. 4557 - 4560
[4] Journal of Medicinal Chemistry, 2011, vol. 54, # 21, p. 7648 - 7662
[5] Patent: US2014/39153, 2014, A1,
  • 4
  • [ 334-48-5 ]
  • [ 29022-11-5 ]
  • [ 1429504-34-6 ]
  • [ 35661-38-2 ]
  • [ 73731-37-0 ]
  • [ 73724-45-5 ]
  • [ 109425-55-0 ]
  • [ 88223-98-7 ]
  • [ 144120-53-6 ]
  • [ 144120-52-5 ]
  • [ 333366-23-7 ]
  • [ 103060-53-3 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 3, p. 748 - 751
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 144120-53-6 ]

Daptomycin Related Intermediates

Chemical Structure| 29022-11-5

[ 29022-11-5 ]

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetic acid

Chemical Structure| 73731-37-0

[ 73731-37-0 ]

(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoic acid

Chemical Structure| 128107-47-1

[ 128107-47-1 ]

Fmoc-D-Ser(tBu)-OH

Chemical Structure| 79990-15-1

[ 79990-15-1 ]

Fmoc-D-Ala-OH

Chemical Structure| 71989-14-5

[ 71989-14-5 ]

Fmoc-Asp(OtBu)-OH

Related Functional Groups of
[ 144120-53-6 ]

Amino Acid Derivatives

Chemical Structure| 86060-83-5

[ 86060-83-5 ]

Fmoc-Asp-Obzl

Similarity: 0.99

Chemical Structure| 146982-24-3

[ 146982-24-3 ]

Fmoc-Asp(OAll)-OH

Similarity: 0.99

Chemical Structure| 177609-12-0

[ 177609-12-0 ]

Fmoc-D-Asp(oall)-OH

Similarity: 0.99

Chemical Structure| 150009-58-8

[ 150009-58-8 ]

Fmoc-D-Asp(OBzl)-OH

Similarity: 0.97

Chemical Structure| 144120-54-7

[ 144120-54-7 ]

Fmoc-Glu-OAll

Similarity: 0.96